Molex Expands European Manufacturing Footprint and Capabilities

Molex's cutting-edge Katowice campus expands regional manufacturing capacity to facilitate timely product delivery of advanced medical devices and electrification solutions to European customers. (Credit: Molex)

Molex , a developer of electronics leader and connectivity products, has expanded its global manufacturing footprint with the opening of a new campus in Katowice, Poland. The facility's initial 23,000-square-meter manufacturing space will serve as a strategic central location to help facilitate timely delivery of advanced medical devices for Phillips-Medisize , a Molex company. Future expansion of up to 85,000 square meters is built into Molex’s growth plans for the facility, further increasing Molex’s presence in Poland, adding to existing sites in Rokitki and Sulęcin.

Molex’s Katowice campus expands regional manufacturing capacity to facilitate timely product delivery of advanced medical devices and electrification solutions to European customers. The campus expands regional manufacturing capacity to facilitate timely product delivery of advanced medical devices and electrification solutions to European customers.

The new Molex Katowice campus reflects a significant investment designed to deliver state-of-the art capabilities in a world-class manufacturing facility and create hundreds of new skilled jobs in this strategic location. The new Molex Katowice campus reflects a significant investment in a world-class manufacturing facility that will create hundreds of new skilled jobs in this strategic location.

“The Katowice campus will expand our European footprint, providing our pharmaceutical, diagnostic and medtech customers with new capabilities and the expert support they need to bring innovative new products to market,” says Paul Chaffin, Phillips-Medisize SVP and president of Molex Medical and Pharma Solutions. “This ultimately allows us to further our vision of enabling patients all over the world to live healthier, more productive lives. We look forward to becoming an active part of the local community, as we work together to create significant value for our customers, our new team members and ultimately patients.”

Molex has so far invested $110 million in these facilities that will initially support Phillips-Medisize with production of pharmaceutical, medical, and diagnostic devices. The site will have state-of-the-art capabilities, including advanced medical device assembly, packaging, drug handling, and injection molding. Additionally, the campus will manufacture interconnect battery solutions for electric vehicles and high-power busbar solutions for Molex's electrification business.

Katowice will complement Phillips-Medisize’s existing operations at six European manufacturing sites in Donegal and Sligo, Ireland; Struer, Denmark; Trhove Sviny, Czech Republic; and two locations in Kontiolahti, Finland.

The large pool of skilled manufacturing and engineering resources in the Katowice area was a major factor influencing Molex's selection of the site location. At planned capacity, the first facilities within the campus will employ approximately 350 employees, including highly skilled production operators, design engineers and quality specialists.

Combining high technology expertise and skilled labor means that both Phillips-Medisize medical customers and Molex automotive and electrification customers now have access to the company's expert capabilities, high-quality services, and support in a location that enables speed-to-market and superior quality in product delivery.

The campus will be the first site for both Molex and Phillips-Medisize to hold a LEED Gold certification. ISO 13485 certification is pending construction completion, with additional certifications and registrations to follow, offering more localized value to those customers who require this exacting manufacturing quality.